Skip to main content
SpringerLink
Log in

Less blood loss with tetrastarch?

  • Correspondence
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hartog CS, Reuter D, Loesche W, Hofmann M, Reinhart K (2011) Influence of hydroxyethyl starch (HES) 130/0.4 on hemostasis as measured by viscoelastic device analysis: a systematic review. Intensive Care Med 37:1725–1737. doi:10.1007/s00134-011-2385-z

    Article  PubMed  CAS  Google Scholar 

  2. Van der Linden PJ, De Hert SG, Deraedt D, Cromheecke S, De Decker K, De Paep R, Rodrigus I, Daper A, Trenchant A (2005) Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for volume expansion in cardiac surgery patients: the effects on perioperative bleeding and transfusion needs. Anesth Analg 101:629–634

    Article  PubMed  Google Scholar 

  3. Hanart C, Khalife M, De Ville A, Otte F, De Hert S, Van der Linden P (2009) Perioperative volume replacement in children undergoing cardiac surgery: albumin versus hydroxyethyl starch 130/0.4. Crit Care Med 37:696–701

    Article  PubMed  CAS  Google Scholar 

  4. Faraoni D, De Villé A, Hofer A, Heschl M, Gombotz H, Van der Linden P. Efficacy and safety of 6 % HES 130/0.4 versus 5% HA for volume replacement during pediatric cardiac surgery. In: Abstract of the American Society of Anesthesiologists, Annual Meeting 2011. Available at: http://www.asaabstracts.com/strands/asaabstracts/abstract.htm;jsessionid=10E9DA4E0F0C2EF1088D49CDF6B4A0F9?year=2011&index=16&absnum=4705. Accessed 22 Dec 2011

  5. James MF, Michell WL, Joubert IA, Nicol AJ, Navsaria PH, Gillespie RS (2011) Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma). Br J Anaesth 107:693–702

    Article  PubMed  CAS  Google Scholar 

  6. Kozek-Langenecker SA, Jungheinrich C, Sauermann W, Van der Linden P (2008) The effects of hydroxyethyl starch 130/0.4 (6 %) on blood loss and use of blood products in major surgery: a pooled analysis of randomized clinical trials. Anesth Analg 107:382–390

    Article  PubMed  CAS  Google Scholar 

  7. Gandhi SD, Weiskopf RB, Jungheinrich C, Koorn R, Miller D, Shangraw RE, Prough DS, Baus D, Bepperling F, Warltier DC (2007) Volume replacement therapy during major orthopedic surgery using Voluven (hydroxyethyl starch 130/0.4) or hetastarch. Anesthesiology 106:1120–1127

    Article  PubMed  CAS  Google Scholar 

  8. Snapinn SM (2000) Noninferiority trials. Current controlled trials in Cardiovascular Medicine 1:19–21

    Article  PubMed  Google Scholar 

  9. Hartog CS, Kohl M, Reinhart K (2011) A systematic review of third-generation hydroxyethyl starch (HES 130/0.4) in resuscitation: safety not adequately addressed. Anesth Analg 112:635–645

    Article  PubMed  CAS  Google Scholar 

  10. Gattas DJ, Dan A, Myburgh J, Billot L, Lo S, Finfer S (2011) Fluid resuscitation with 6 % hydroxyethyl starch (130/0.4) in acutely ill patients: an updated systematic review and meta-analysis. Anesth Analg 114:159–169

    Article  Google Scholar 

  11. de Jonge E, Levi M (2001) Effects of different plasma substitutes on blood coagulation: a comparative review. Crit Care Med 29:1261–1267

    Article  PubMed  Google Scholar 

  12. Department of Health and Human Services, Food and Drug Administration (1998). List of drug products that have been withdrawn or removed from the market for reasons of safety or effectiveness. 21 CFR part 216 [Docket No. 98 –0655]. FDA, Washington D.C.

  13. Haynes GR, Havidich JE, Payne KJ (2004) Why the Food and Drug Administration changed the warning label for hetastarch. Anesthesiology 101:560–561

    Article  PubMed  Google Scholar 

  14. Hartog C, Brunkhorst F, Reinhart K (2009) Hydroxyethyl starch 130/0.4 and surgical blood loss. Anesth analg 108:672 (author reply 672–673)

    Google Scholar 

  15. Replys. E-letter. Available at: http://bja.oxfordjournals.org/content/107/5/693/reply. Accessed 22 Dec 2011

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesiology and Intensive Care Medicine, University Hospital Jena, Erlanger Allee 101, 07747, Jena, Germany

    Christiane S. Hartog & Konrad Reinhart

Authors
  1. Christiane S. Hartog
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Konrad Reinhart
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Konrad Reinhart.

Additional information

This reply refers to the comment available at: doi:10.1007/s00134-012-2552-x.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hartog, C.S., Reinhart, K. Less blood loss with tetrastarch?. Intensive Care Med 38, 1080–1081 (2012). https://doi.org/10.1007/s00134-012-2553-9

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-012-2553-9

Keywords

Search

Navigation